In MOG antibody associated demyelinating disease, studies have demonstrated that the Breg cells such as CD19+CD24hiCD38hi and CD19+CD5+CD1dhi B cells are numerically low and functionally impaired (148). This evidence concerns the gene CD19 and demyelinating disease.